Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Debt Ratio (2016 - 2017)

Corcept Therapeutics (CORT) has disclosed Debt Ratio for 6 consecutive years, with 0.05 as the latest value for Q2 2017.

  • For Q2 2017, Debt Ratio fell 86.53% year-over-year to 0.05; the TTM value through Jun 2017 reached 0.05, down 86.53%, while the annual FY2016 figure was 0.21, 59.74% down from the prior year.
  • Debt Ratio hit 0.05 in Q2 2017 for Corcept Therapeutics, down from 0.13 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.98 in Q4 2014 and bottomed at 0.05 in Q2 2017.
  • Average Debt Ratio over 5 years is 0.51, with a median of 0.51 recorded in 2013.
  • Year-over-year, Debt Ratio skyrocketed 91.27% in 2014 and then tumbled 86.53% in 2017.
  • Corcept Therapeutics' Debt Ratio stood at 0.56 in 2013, then surged by 76.03% to 0.98 in 2014, then crashed by 45.87% to 0.53 in 2015, then crashed by 59.74% to 0.21 in 2016, then plummeted by 75.22% to 0.05 in 2017.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.05, 0.13, and 0.21 for Q2 2017, Q1 2017, and Q4 2016 respectively.